Recently, a California appeals court dismissed the Hobbs v Verizon Qui Tam Whistleblower lawsuit (hobbs v verizon qui tam whistleblower lawsuit). In the Hobbs v Verizon Qui Tam Whistleblower Lawsuit, the plaintiff made allegations that Verizon failed to collect sufficient taxes from its customers. The Hobbs v Verizon Qui Tam Whistleblower […]
Monthly Archives: February 2014
Recently, the USDC – District of New Jersey dismissed the Medco Health Qui Tam Whistleblower lawsuit (medco health qui tam whistleblower lawsuit). The Medco Health Qui Tam Whistleblower lawsuit was dismissed because the case was not plead with the requisite facts and particularity to satisfy federal pleading requirements. Under the […]
Medco Health Qui Tam Whistleblower Lawsuit
Researchers have published an article about a predictive biomarker for mesothelioma. The researchers in the study about the predictive biomarker for mesothelioma seem to have found that the plasma fibrogen levels in malignant pleural mesothelioma (mpm) patients are good indicators for planning treatment regimens related to surgery. The researchers found […]
Predictive Biomarker For Mesothelioma
The Pennsylvania Supreme Court ruled in the most recent (redux) fen phen lawsuit that the maker of the weight-loss diet drug fen phen, redux etc. that took off and went bust in the diet drug craze must face claims that its warning labels were inadequate. The latest Fen phen lawsuit […]
Fen Phen Lawsuit
The Department of Justice announced that it intervened and reached a settlement in the Medtronic Spine LLC, the corporate successor to Kyphon Inc., Medtronic Kyphon Qui Tam whistleblower lawsuit in which Medtronic Kyphon has agreed to pay a total of $75 million to settle allegations that it caused the submission of […]
Medtronic Kyphon Qui Tam Whistleblower Lawsuit
The Department of Justice announced that it intervened and reached a settlement in the Diagnostic Imaging Group Qui Tam whistleblower lawsuit in which Diagnostic Imaging Group has agreed to pay a total of $15.5 million to resolve allegations that its diagnostic testing facility falsely billed federal and state health care programs […]
Diagnostic Imaging Group Qui Tam Whistleblower Lawsuit
Recently, the FDA received a letter related to adding a low testosterone warning to the label of the prescription testosterone therapy products on the market. The group – Public Citizen – filed the petition for a low testosterone warning – a “black box warning about the increased risks of heart […]
Low Testosterone Warning
The Department of Justice announced that it intervened and reached a settlement in the Sanborn Map Qui Tam whistleblower lawsuit in which Sanborn Map Company Inc. has agreed to pay $2.1 million to the U.S. government to resolve allegations that it submitted false claims in connection with U. S. Army […]
Sanborn Map Qui Tam Whistleblower Lawsuit
The Department of Justice announced that it intervened and reached a settlement in the MPRI qui tam whistleblower lawsuit in which MPRI has agreed to pay $3.2 million to resolve allegations that it submitted false labor charges on a contract to support the Army in Afghanistan. The MPRI qui tam […]
MPRI Qui Tam Whistleblower Lawsuit
A clinical low testosterone trial began to test the hypotheses that testosterone treatment of elderly men whose serum testosterone concentrations are unequivocally low – and who have symptoms and objectively measured abnormalities in at least one of five areas that could be due to low testosterone (physical or sexual function, […]